News

Phathom Pharmaceuticals Announces Upcoming Investor Engagements

Phathom Pharmaceuticals Announces Upcoming Investor Engagements

Phathom Pharmaceuticals Upcoming Investor Conferences

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a dedicated biopharmaceutical company, is making strides in the realm of gastrointestinal (GI) diseases. The company aims to develop groundbreaking treatments that can substantially improve the lives of patients suffering from such conditions. Today, we share exciting news about the company’s participation in several important investor conferences scheduled for the upcoming months.

Highlighted Conference Participation

The management team at Phathom Pharmaceuticals is gearing up to present at various conferences where they will engage with investors, showcasing their innovative solutions and discussing their vision for the future. Here’s a glimpse of their scheduled appearances:

Guggenheim's Inaugural Healthcare Innovation Conference

This premier event takes place in Boston. The conference will feature a live webcast event on the morning of November 12, where Phathom’s management is expected to participate in targeted one-on-one meetings. This platform provides them an opportunity to elaborate on their new initiatives and answer investor inquiries.

Stifel 2024 Healthcare Conference

Another important event is the Stifel Healthcare Conference in New York, set for November 18. Phathom’s management will engage with attendees during scheduled meetings to discuss their pioneering treatments and ongoing enhancements in their development programs.

Jefferies London Healthcare Conference

Moving across the ocean, the Jefferies London Healthcare Conference on November 20 will give Phathom an international platform to connect with global investors. The management team's participation underscores their commitment to broadening relationships with shareholders.

7th Annual Evercore HealthCONx Conference

This much-anticipated event in Coral Gables, happening on December 3, will again give the management team a chance to highlight their latest accomplishments and strategic goals in front of investment professionals.

Accessing Conference Information

Listening to these discussions and presentations is vital for investors who want to keep a finger on the pulse of Phathom Pharmaceuticals’ advancements. Interested individuals can access the live webcasts and obtain archived recordings on the Phathom Pharmaceuticals website. This makes it convenient for stakeholders to catch up with real-time insights and future plans.

About Phathom Pharmaceuticals

Phathom Pharmaceuticals is committed to redefining treatment landscapes within gastrointestinal health. Their flagship product, vonoprazan, represents a significant step forward in the treatment of various GI disorders, including Non-Erosive GERD and the eradication of H. pylori infection in adults. Marketed as VOQUEZNA, this innovative product is gaining momentum as an industry leader. The company aims to continue expanding its portfolio, focusing on drawing from innovative methods and strategic collaborations for future solutions.

Stay Connected with Phathom

For ongoing updates and further information, stakeholders are encouraged to visit Phathom's official website and follow them on LinkedIn and X to remain informed about their trajectory. Phathom is on a mission to ensure that effective treatments for GI diseases are accessible to those in need.

Frequently Asked Questions

What is Phathom Pharmaceuticals focused on?

Phathom Pharmaceuticals is focused on developing and commercializing innovative treatments for gastrointestinal diseases, particularly with their lead product, vonoprazan.

When is Phathom participating in conferences?

Phathom Pharmaceuticals will participate in several key conferences in November and December, including events in Boston, New York, London, and Coral Gables.

How can I access the webcasts of the conferences?

You can access live webcasts and recordings of the conferences through the News & Events section of the Phathom website.

What does vonoprazan treat?

Vonoprazan treats conditions like heartburn associated with Non-Erosive GERD and helps in the healing of Erosive GERD while also addressing H. pylori infections.

How can I stay updated with Phathom Pharmaceuticals?

For the latest updates, you can visit their official website and follow them on platforms like LinkedIn and X.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Q32 Bio's Ambitious Steps into Global Conferences

Updated Category News Views 39

Q32 Bio Takes the Stage at Jefferies Who would've thought? Q32 Bio, strutting their stuff at the 2026 Jefferies Global Healthcare Conference in London. Mark your calendars, folks, for November 18, 2026, because that's when they're jumping into the spotlight with a fireside chat. This event isn't just another tiny ripple; it's a chance for Q32 to showcase their innovative...

Continue Reading
Bramshill Fund Takes Top Spot in 2026 Fund Awards

Updated Category News Views 78

Another Feather in Bramshill's Cap They've done it again, folks. The Bramshill Multi-Strategy Income Fund has just snagged the 40 Act Fund of the Year award at the 2026 Hedge Fund Performance Awards. This ain't just another plaque for the wall; it's a nod to some serious heavy lifting by the folks handling this beast of a portfolio. The award, dished out by With...

Continue Reading
MyyShop Poised to Redefine the Creator Economy

Updated Category News Views 18

Breaking Ground in Creator Ecosystems MyyShop isn't just a player in the creator economy; it's trying to change the damned rules. By focusing intensely on co-creation and learning, MyyShop's putting its chips on creating an inclusive and sustainable space where creators aren't just participants but the ones calling the shots. Catalyzing Co-Creation Everybody in the game...

Continue Reading
Alogent's Unify Snags Award for Innovation and Impact

Updated Category News Views 136

Innovation That Captures Attention Alogent sure did grab the spotlight with their Unify platform walking away with a Credit Union Times Luminaries Award. The name of the game here is deposit processing innovation—the kind of buzz that turns heads in the banking world. This recognition isn't just another plaque for the lobby; it's a testament to a significant stamp on...

Continue Reading
Trade Show Displays: Finding Your Best Fit

Updated Category News Views 39

Nailing Your Trade Show Presence Trade shows are a battleground where seconds decide if your booth's a hit or a flop. Asking the right questions about your display could mean the difference between sparking interest or getting lost in the noise. FASTSIGNS is on the ball with their guide designed to help exhibitors compare display options like retractable banner stands,...

Continue Reading
Yeastar 2026 Summit: AI, Growth, and Global Vision

Updated Category News Views 107

Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...

Continue Reading
SAFE WALL PLATE: Shielding Homes from Electric Hazards

Updated Category News Views 31

Innovative Twist on a Common Household Item Most folks don't give a second thought to the humble wall plate. It's just something you see, not something you think about until—bam!—sparks fly. But here's the scribble from a couple of bright minds down in Elko, Nev.: they've cooked up something called the SAFE WALL PLATE. Their goal? To patch up a glaring safety flaw...

Continue Reading
SwitchBot Unveils Curtain Track 4: Less Hassle, More Smarts

Updated Category News Views 13

SwitchBot's Ambitious Leap in Curtain Automation Well, it seems like SwitchBot is shaking things up in the world of home automation. They’re rolling out the Curtain Track 4, and it’s packed with enhancements that aim to make your drapery as lazy as you are. Imagine getting up close without any fuss—just a neat 30-second setup on those U-rail curtains and we’re off...

Continue Reading
Lean Focus Expands: Bridging Global Expertise in APAC

Updated Category News Views 119

A New Era for Lean Focus in the Asia Pacific The wave of business dynamics in APAC just got a little more intense. Lean Focus has thrown its hat in the ring, expanding into the Asia Pacific—a move that could shift how businesses operate in this bustling region. Forget the corporate hype for a moment and think about what this really means: local expertise, hands-on...

Continue Reading
PMET's Lithium-Tantalum Study Ups Stakes in Québec Project

Updated Category News Views 108

Elevated Ambitions in Québec: PMET's Lithium-Tantalum Leap PMET Resources just handed us an intriguing update on their Shaakichiuwaanaan project up in Québec. They're reshaping the roadmap to crank out both lithium and tantalum more efficiently than a bear on a honeycomb. The revised feasibility study has put to paper numbers that have optimists—and skeptics...

Continue Reading

Top 5 Most Recently Viewed Articles

Blair Hagkull Strengthens QuadReal's Board with Expertise

Updated Category News Views 123

Blair Hagkull Joins QuadReal's Board of Directors QuadReal Property Group is thrilled to share that Blair Hagkull has officially joined its Board of Directors. With a distinguished career that spans 35 years in international real estate, Blair brings a wealth of knowledge along with a fresh, innovative perspective to the company. Experience Across Continents Blair...

Continue Reading
Webus International Unveils Innovative AI-Driven Loyalty Agent

Updated Category News Views 139

Introducing Webus International Limited’s Latest Innovation Webus International Limited (NASDAQ: WETO), a pioneering company in the Travel Tech sector, has recently announced the launch of its groundbreaking AI-powered points optimization platform. This innovative platform, which utilizes OpenAI’s AgentKit framework, marks a significant step in enhancing the Company's...

Continue Reading
National Bank Investments Simplifies Fund and ETF Offerings

Updated Category News Views 54

National Bank Investments Streamlines Fund and ETF Offerings National Bank Investments Inc. (NBI) is making a strategic decision to simplify its investment options by discontinuing the NBI Canadian Family Business ETF (ticker symbol: NFAM) along with the NBI Canadian Preferred Equity Private Portfolio. These changes demonstrate NBI's dedication to refining its investment...

Continue Reading
SHEIN's Commitment to Sustainability and Net-Zero Emissions

Updated Category News Views 555

SHEIN's Journey Towards Sustainable Fashion In a significant move for the fashion industry, SHEIN, a leading online global retailer, has made a groundbreaking announcement about its commitment to sustainability. This initiative involves ambitious net-zero targets validated by the Science Based Targets initiative (SBTi). These targets signify an essential step in SHEIN's...

Continue Reading
Trane Technologies Sets Ambitious 2030 Carbon Reduction Goals

Updated Category News Views 79

Trane Technologies Unveils Ambitious Carbon Reduction Goals for 2030 Trane Technologies (NYSE: TT), a leader in climate innovation, has just announced a bold initiative aimed at reducing embodied carbon by 40% by 2030. This ambitious plan represents a significant step in the company's ongoing sustainability efforts and sets an inspiring example for the industry. What is...

Continue Reading